The Greenberg Traurig China Newsletter provides an overview of key developments in Chinese legislation. This issue features the following articles:
- CFDA Provides Clarity on Administration of Imported Drug Registration
- CIRC to Standardize Internal Control System for Use of Insurance Funds
- SZSE Strengthens Information Disclosure for Joint Investment Made by Listed Companies and Specialized Investment Institutions
- CFDA Sought Public Opinions on the Draft Amendments to the Drug Administration Law and the Regulations for Supervision and Administration of Medical Devices
- First-Time Amendments to Anti-Unfair Competition Law Issued
- NDRC Issues Administrative Measures for Outbound Investment of Enterprises
- MOF and SAT Improve Tax Credit Policy for Enterprises’ Foreign-Sourced Income
- Profits Distributed to Overseas Investors Exempt from Withholding Tax if Used for Direct Investment